187 related articles for article (PubMed ID: 38049185)
1. Puberty Assessment and Consideration of Gonadotropin-Releasing Hormone Agonists in Transgender and Gender-Diverse Youth.
Lee JY
Pediatr Ann; 2023 Dec; 52(12):e462-e466. PubMed ID: 38049185
[TBL] [Abstract][Full Text] [Related]
2. Growth in Transgender/Gender-Diverse Youth in the First Year of Treatment With Gonadotropin-Releasing Hormone Agonists.
Schulmeister C; Millington K; Kaufman M; Finlayson C; Kennedy JO; Garofalo R; Chan YM; Rosenthal SM
J Adolesc Health; 2022 Jan; 70(1):108-113. PubMed ID: 34315674
[TBL] [Abstract][Full Text] [Related]
3. Review: Puberty blockers for transgender and gender diverse youth-a critical review of the literature.
Rew L; Young CC; Monge M; Bogucka R
Child Adolesc Ment Health; 2021 Feb; 26(1):3-14. PubMed ID: 33320999
[TBL] [Abstract][Full Text] [Related]
4. Association of Gonadotropin-Releasing Hormone Analogue Use With Subsequent Use of Gender-Affirming Hormones Among Transgender Adolescents.
Nos AL; Klein DA; Adirim TA; Schvey NA; Hisle-Gorman E; Susi A; Roberts CM
JAMA Netw Open; 2022 Nov; 5(11):e2239758. PubMed ID: 36318207
[TBL] [Abstract][Full Text] [Related]
5. Gender-Affirming Care of Transgender and Gender-Diverse Youth: Current Concepts.
Lee JY; Rosenthal SM
Annu Rev Med; 2023 Jan; 74():107-116. PubMed ID: 36260812
[TBL] [Abstract][Full Text] [Related]
6. Urological and Gynaecological Considerations for the Use of Gonadotropin-releasing Hormone Analogues in Transgender and Nonbinary Adolescents: A Narrative Review.
Lee WG; Butler G; Carmichael P; Rashid T; Yasmin E; Morley R; Barrett J; Christopher N; Sangster P
Eur Urol Focus; 2023 Jan; 9(1):35-41. PubMed ID: 36396559
[TBL] [Abstract][Full Text] [Related]
7. Children and adolescents in the Amsterdam Cohort of Gender Dysphoria: trends in diagnostic- and treatment trajectories during the first 20 years of the Dutch Protocol.
van der Loos MATC; Klink DT; Hannema SE; Bruinsma S; Steensma TD; Kreukels BPC; Cohen-Kettenis PT; de Vries ALC; den Heijer M; Wiepjes CM
J Sex Med; 2023 Feb; 20(3):398-409. PubMed ID: 36763938
[TBL] [Abstract][Full Text] [Related]
8. Transgender Dependent Adolescents in the U.S. Military Health Care System: Demographics, Treatments Sought, and Health Care Service Utilization.
Van Donge N; Schvey NA; Roberts TA; Klein DA
Mil Med; 2019 May; 184(5-6):e447-e454. PubMed ID: 30325452
[TBL] [Abstract][Full Text] [Related]
9. Biopsychosocial Assessments for Pubertal Suppression to Treat Adolescent Gender Dysphoria.
Turban JL; Thornton J; Ehrensaft D
J Am Acad Child Adolesc Psychiatry; 2024 Apr; ():. PubMed ID: 38582366
[TBL] [Abstract][Full Text] [Related]
10. Growth, growth potential, and influences on adult height in the transgender and gender-diverse population.
Roberts SA; Carswell JM
Andrology; 2021 Nov; 9(6):1679-1688. PubMed ID: 33969625
[TBL] [Abstract][Full Text] [Related]
11. Association of Pubertal Blockade at Tanner 2/3 With Psychosocial Benefits in Transgender and Gender Diverse Youth at Hormone Readiness Assessment.
McGregor K; McKenna JL; Williams CR; Barrera EP; Boskey ER
J Adolesc Health; 2024 Apr; 74(4):801-807. PubMed ID: 38099903
[TBL] [Abstract][Full Text] [Related]
12. Bone Health in the Transgender and Gender Diverse Youth Population.
Lee JY
Curr Osteoporos Rep; 2023 Aug; 21(4):459-471. PubMed ID: 37395890
[TBL] [Abstract][Full Text] [Related]
13. Development of Hip Bone Geometry During Gender-Affirming Hormone Therapy in Transgender Adolescents Resembles That of the Experienced Gender When Pubertal Suspension Is Started in Early Puberty.
van der Loos MA; Hellinga I; Vlot MC; Klink DT; den Heijer M; Wiepjes CM
J Bone Miner Res; 2021 May; 36(5):931-941. PubMed ID: 33507568
[TBL] [Abstract][Full Text] [Related]
14. Trajectories of Adolescents Treated with Gonadotropin-Releasing Hormone Analogues for Gender Dysphoria.
Brik T; Vrouenraets LJJJ; de Vries MC; Hannema SE
Arch Sex Behav; 2020 Oct; 49(7):2611-2618. PubMed ID: 32152785
[TBL] [Abstract][Full Text] [Related]
15. Systematic Review: Puberty suppression with GnRH analogues in adolescents with gender incongruity.
Ramos GGF; Mengai ACS; Daltro CAT; Cutrim PT; Zlotnik E; Beck APA
J Endocrinol Invest; 2021 Jun; 44(6):1151-1158. PubMed ID: 33111215
[TBL] [Abstract][Full Text] [Related]
16. Care for Transgender Young People.
Krebs D; Harris RM; Steinbaum A; Pilcher S; Guss C; Kremen J; Roberts SA; Baskaran C; Carswell J; Millington K
Horm Res Paediatr; 2022; 95(5):405-414. PubMed ID: 35272283
[TBL] [Abstract][Full Text] [Related]
17. Gender affirming medical care of transgender youth.
Salas-Humara C; Sequeira GM; Rossi W; Dhar CP
Curr Probl Pediatr Adolesc Health Care; 2019 Sep; 49(9):100683. PubMed ID: 31735692
[TBL] [Abstract][Full Text] [Related]
18. Back to the Future: Is GnRHa Treatment in Transgender and Gender Diverse Adolescents Only an Extended Evaluation Phase?
Fisher AD; Ristori J; Romani A; Cassioli E; Mazzoli F; Cocchetti C; Pierdominici M; Marconi M; Ricca V; Maggi M; Vignozzi L; Castellini G
J Clin Endocrinol Metab; 2024 May; 109(6):1565-1579. PubMed ID: 38099569
[TBL] [Abstract][Full Text] [Related]
19. Blood pressure dynamics after pubertal suppression with gonadotropin-releasing hormone analogs followed by estradiol treatment in transgender female adolescents: a pilot study.
Perl L; Elkon-Tamir E; Segev-Becker A; Israeli G; Brener A; Oren A
J Pediatr Endocrinol Metab; 2021 Jun; 34(6):741-745. PubMed ID: 33823098
[TBL] [Abstract][Full Text] [Related]
20. Psychosocial Characteristics of Transgender Youth Seeking Gender-Affirming Medical Treatment: Baseline Findings From the Trans Youth Care Study.
Chen D; Abrams M; Clark L; Ehrensaft D; Tishelman AC; Chan YM; Garofalo R; Olson-Kennedy J; Rosenthal SM; Hidalgo MA
J Adolesc Health; 2021 Jun; 68(6):1104-1111. PubMed ID: 32839079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
